WebMD tackles childhood obesity with new websites

Share this article:
WebMD tackles childhood obesity with new websites
WebMD tackles childhood obesity with new websites
WebMD is expanding its wellness and prevention offering with several children's fitness sites aimed at besting childhood obesity.

The sites – Fit Junior, for ages 2-7, Fit Kids, for ages 8-12, and Fit Teens, for ages 13-19, along with a site for parents called Raising Fit Kids – are WebMD's first for kids, and come as part of an educational partnership with Sanford Health, a top non-profit rural healthcare provider and a leader in children's medical research. The sites will offer personalized resources and support to help promote and maintain a healthy lifestyle for kids based on “the four factors of healthy living: food, mood, recharge and move.”
On the professional side, Medscape will offer resources aimed at helping physicians combat childhood obesity among their patients.

The publisher doesn't yet have advertisers lined up for the sites but is in talks with “several large corporate sponsors,” a spokesperson said.
“We are committed to improving the health of children and their families across all health and wellness issues and we can't think of anything more important than the prevention of childhood obesity,” said CEO Wayne Gattinella.

According to Centers for Disease Control data, childhood obesity now affects 17% of children and adolescents in the US – triple the rate from just a generation ago – and one in seven preschool-aged low-income kids.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...